No registrations found.
ID
Source
Brief title
Health condition
Respiratory wheeze in pre-school children
Pediatric Asthma
Sponsors and support
Intervention
Outcome measures
Primary outcome
Astma as determined by bronchial hyperreactivity testing at age 6.
Secondary outcome
N/A
Background summary
Study synopsis:
Confirmed wheezing in infancy as basis for molecular fingerprinting in the prediction of asthma. EuroPA study.
Rationale:
Young children with confirmed wheeze do already exhibit the major histological features of asthma. There is increasing evidence that microbial and biological characteristics can improve the phenotyping of infants at risk of asthma. The aim of the present study is to use confirmed wheezing as the basis for the application of modern molecular profiling in the prediction of asthma in young children.
Hypothesis:
We postulate that the development of asthma in preschool children can be captured during the first 2 years of life by a minimally invasive ‘fingerprint’.
Methods:
Patients - 1000 infants (< 2 years):
An estimated:
1. 330 patients will present with parent reported wheeze of which 130 will exhibit confirmed wheeze;
2. 100 aged matched infants will be used as controls from the same cohort.
Study design:
3-phase 6 years prospective follow-up study:
1. Phase 1 (2 yrs duration): inclusion and baseline assessments in wheezy infants and their healthy age-matched controls during the first 2 years of life;
2. Phase 2 (2 yrs duration): monitoring of respiratory symptoms;
3. Phase 3 (2 yrs duration): outcome assessment of the children for the presence of objective criteria for asthma at age 5.
Primary outcome:
Asthma at the age of 5 years, objectively established on basis of a validated combination of symptoms and/or the use of asthma medication, in combination with spirometry and increased bronchial hyper responsiveness, based upon the then applicable international standards.
Methods:
Predictors will be gathered by means of:
1. Wheeze confirmation;
2. Exhaled air: Molecular pattern recognition by electronic nose;
3. Nasal aspirate and throat swab: Viral and typical/atypical bacterial detection by qPCR;
4. Molecular phenotyping: Quantitative PCR analysis, cellular and soluble immunological
markers, and multiplex antibody measurements in whole venous blood samples.
Analysis:
Associations between predictors and outcome will be examined by univariate analysis and predictive logistic models.
Relevance:
The concept of confirmed wheezing can be considered as a new clinical opportunity to provide phenotype-specific management in preschool children. By combining this with molecular profiling, our study aims to provide a clinical-molecular signature for the prediction of asthma. We hope that this can be applied for the development of focused treatment and prevention.
Study objective
We postulate that the development of asthma in preschool children can be captured during the first 2 years of life by a minimally invasive ‘fingerprint’.
Study design
Asthma at age 6.
Intervention
None, the study is purely observational.
1100 DD Amsterdam
Marc P.C. Schee, van der
Clinical Research Fellow 'Europa-study'
Academic Medical Center
University of Amsterdam
Dept. Pulmonology, F5-158
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 - 20 - 566 8375
m.p.vanderschee@amc.uva.nl
1100 DD Amsterdam
Marc P.C. Schee, van der
Clinical Research Fellow 'Europa-study'
Academic Medical Center
University of Amsterdam
Dept. Pulmonology, F5-158
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 - 20 - 566 8375
m.p.vanderschee@amc.uva.nl
Inclusion criteria
All children aged under 18 months will be included in the cohort.
Exclusion criteria
Age over 18 months.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL1844 |
NTR-old | NTR1955 |
Other | Dutch Astma Foundation : 3.4.08.019 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |